|
May 5
|
NexgenRx Inc.'s (CVE:NXG) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
|
|
Oct 1
|
NexgenRx Announces New Director
|
|
Apr 5
|
NexgenRx Announces 2023 Year End Results With Solid Revenue Growth, Continuing Positive EBITDA
|
|
Dec 29
|
NexgenRx Announces Director Resignation
|
|
Dec 20
|
NexgenRX Announces Declaration of Dividend
|